Byrd, John C.

Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies

Stephens, D. M., & Byrd, J. C. (2021) · Blood

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 37

Modulation of immune checkpoint molecule expression in mantle cell lymphoma

Harrington, B. K., Wheeler, E., Hornbuckle, K., Shana’ah, A. Y., Youssef, Y., Smith, L., Hassan II, Q., Klamer, B., Zhang, X., Long, M., et al. (2019) · Leukemia & Lymphoma

Lymphoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 31

Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia

Morrison, E. J., Flynn, J. M., Jones, J., Byrd, J. C., & Andersen, B. L. (2016) · Annals of Hematology

Cancer survivorship and careChronic Lymphocytic Leukemia Research

Cited by 25

Characterization of Mechanisms of Resistance in Previously Treated Chronic Lymphocytic Leukemia (CLL) From a Head‐to‐Head Trial of Acalabrutinib Versus Ibrutinib

Woyach, J. A., Jones, D., Jurczak, W., Robak, T., Illés, A., Kater, A. P., Ghia, P., Byrd, J. C., Seymour, J. F., Long, S., et al. (2023) · Hematological Oncology

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 12